Phaarmasia Ltd

Phaarmasia Ltd (PHRMASI) is a micro-cap Healthcare company valued at ₹55 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Phaarmasia Ltd last traded at ₹80, unchanged on the day.

Recent developments

On 2026-06-30, the company reported a net profit of ₹0 crore for the latest quarter, matching the same quarter a year earlier, despite a 20.5% rise in revenue to ₹8 crore. In the previous quarter, the company recorded a net loss of ₹1 crore, which was higher than the ₹0 crore loss in the same quarter a year earlier.

Financial performance

The company's business has improved significantly, with annual revenue rising 93.7% to ₹47 crore and net profit swinging from a loss of ₹2 crore to a profit of ₹18 crore. However, the latest quarter showed a net profit of ₹0 crore, down from ₹0 crore in the same quarter a year earlier, while revenue rose 20.5% to ₹8 crore.

Valuation multiples

The stock trades at 3.1 times earnings, a discount to the Healthcare median of 32.0, 2.72 times book value.

Things to watch

The company's latest quarter net profit remained at ₹0 crore, which is flat compared to the same quarter a year earlier. The stock is 39.3% below its 52-week high, and promoter holding is at 73.51%, with no foreign institutional holding.

Where it stands

Phaarmasia Ltd has seen strong annual revenue growth and a turnaround in net profit, but the latest quarter shows no improvement in net profit. The stock is significantly below its 52-week high, and the company remains almost debt-free with a high return on equity.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.